Literature DB >> 28466549

A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System.

Sung-Hoon Jung1, Kihyun Kim2, Jin Seok Kim3, Seok Jin Kim2, Jung-Won Cheong3, Soo-Jeoong Kim3, Jae-Sook Ahn1, Seo-Yeon Ahn1, Deok-Hwan Yang1, Hyeoung-Joon Kim1, Je-Jung Lee1.   

Abstract

Entities:  

Keywords:  multiple myeloma; prognosis; risk factors

Mesh：

Year:  2017        PMID： 28466549     DOI： 10.1111/bjh.14701

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System.

Authors:  Sung-Hoon Jung; Seong Young Kwon; Jung-Joon Min; Hee-Seung Bom; Seo-Yeon Ahn; Seung-Yeon Jung; Seung-Shin Lee; Moo-Rim Park; Deok-Hwan Yang; Jae-Sook Ahn; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-05       Impact factor: 9.236

Review 2.  Progress of modern imaging modalities in multiple myeloma.

Authors:  Toshiki Terao; Kosei Matsue
Journal:  Int J Hematol       Date:  2022-05-09       Impact factor: 2.490

3.  Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT.

Authors:  Je-Jung Lee; Joon Ho Moon; Hee Jeong Cho; Sung-Hoon Jung; Jae-Cheol Jo; Yoo Jin Lee; Sang Eun Yoon; Sung-Soo Park; Do Young Kim; Ho-Jin Shin; Yeung-Chul Mun; Jun Ho Yi; Hyo Jung Kim; Da Jung Kim; Ho Sup Lee; Sung Hwa Bae; Chae Moon Hong; Shin Young Jeong; Jung-Joon Min; Sang Kyun Sohn; Chang-Ki Min; Kihyun Kim
Journal:  Blood Cancer J       Date:  2021-12-01       Impact factor: 11.037

4.  Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.

Authors:  Ga-Young Song; Sung-Hoon Jung; Kihyun Kim; Seok Jin Kim; Sang Eun Yoon; Ho Sup Lee; Mihee Kim; Seo-Yeon Ahn; Jae-Sook Ahn; Deok-Hwan Yang; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  BMC Cancer       Date:  2020-08-24       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.